2025-03-24 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis

This report analyzes Colgate-Palmolive Co (CL), a leading global consumer goods company specializing in oral hygiene, personal care, and household products.

**1) Performance Comparison & Alpha/Beta Analysis:**

Colgate-Palmolive's cumulative return (43.41%) significantly underperformed the S&P 500 (VOO) with a cumulative return of 104.98%. The difference is -61.6%, placing it at the 29.1st percentile of its historical range of performance relative to the S&P 500 (-90.2% to 8.1%).

The provided Alpha/Beta analysis shows inconsistent performance relative to the market.  While the Alpha suggests periods of outperformance (particularly 2018-2021),  negative CAGR is observed in some years (2016-2018).  Beta generally hovers around 1, indicating similar volatility to the market.  Market capitalization fluctuates between approximately $40B and $70B over the period.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 13.0% | 4.8% | -15.0% | 0.0 | 51.5 |
| 2016-2018  | -12.0% | 8.6% | -30.0% | 0.0 | 41.6 |
| 2017-2019  | 9.0% | 8.6% | -21.0% | 0.2 | 49.4 |
| 2018-2020  | 21.0% | 8.6% | -6.0% | 0.7 | 62.8 |
| 2019-2021  | 32.0% | 7.3% | -39.0% | 1.0 | 64.1 |
| 2020-2022  | 7.0% | 9.4% | -2.0% | 1.0 | 60.6 |
| 2021-2023  | 3.0% | 9.4% | -20.0% | 1.0 | 62.9 |
| 2022-2024  | 12.0% | 9.4% | -20.0% | 1.0 | 73.4 |
| 2023-2025  | 29.0% | 74.6% | 0.5 | 73.3 |


**2) Recent Price Movement:**

* **Closing Price:** $90.30
* **5-day Moving Average:** $90.24
* **20-day Moving Average:** $91.68
* **60-day Moving Average:** $89.37

The price is slightly below the 5-day and significantly below the 20-day moving average, suggesting a short-term bearish trend.  However, it is above the 60-day moving average, indicating a longer-term potential upward trend.  The recent price change of $0.02 is not significant enough to indicate a sudden surge or drop.

**3) Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.42 (Medium Risk)
* **RSI:** 43.43 (Approaching oversold territory, but not decisively so)
* **PPO:** -0.45 (Bearish signal)
* **Relative Strength Change (20-day):** -0.9 (Short-term bearish trend)
* **Expected Return:** -108.6% (This extremely negative figure requires further investigation and context.  It likely represents a significant underperformance expectation relative to the S&P 500 over a long-term investment horizon,  potentially reflecting the current underperformance shown in point 1).


**4) Recent Earnings Analysis:**

The recent earnings show relatively stable revenue around $5B, with slight fluctuations. EPS is also relatively stable, indicating consistent profitability.  There is repetition in the data for October 2024, suggesting a potential data entry error.

| Date       | EPS | Revenue     |
|------------|-----|-------------|
| 2024-10-25 | 0.9 | $5.03 B     |
| 2024-07-26 | 0.89 | $5.06 B     |
| 2024-04-26 | 0.83 | $5.07 B     |
| 2023-10-27 | 0.86 | $4.92 B     |
| 2024-10-25 | 0.86 | $4.92 B     |


**5) Financial Information:**

Revenue remains relatively consistent, with profit margins hovering around 60%.  The ROE figures are exceptionally high and volatile (potentially due to data errors or accounting practices specific to Colgate), warranting further investigation.   The equity figures also show significant quarter-to-quarter variation.

Revenue and Profitability:

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $4.95B | 60.30% |
| 2024-09-30 | $5.03B | 61.08% |
| 2024-06-30 | $5.06B | 60.62% |
| 2024-03-31 | $5.07B | 60.00% |
| 2023-12-31 | $4.95B | 59.60% |

Capital and Profitability:

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $0.21B | 348.58% |
| 2024-09-30 | $0.43B | 169.43% |
| 2024-06-30 | $0.12B | 594.31% |
| 2024-03-31 | $0.23B | 296.96% |
| 2023-12-31 | $0.61B | 117.90% |


**6) Overall Conclusion:**

Colgate-Palmolive shows relatively stable revenue and earnings but has significantly underperformed the S&P 500 over the analyzed period.  Technical indicators suggest a neutral to slightly bearish short-term outlook.  The high volatility and seemingly anomalous data in the ROE and Equity figures raise concerns requiring further investigation. The -108.6% expected return is highly improbable and needs clarification.  Before making any investment decisions, a thorough review of the financial statements and a deeper analysis of the -108.6% expected return figure are crucial.  The data provided contains inconsistencies (repeated entries) that must be resolved before drawing definitive conclusions.
